Biotech Stocks News & Investing Tips

New AI Breakthrough Will Blindside Millions. Will You be One of Them?

On Feb. 13, AI expert Luke Lango will reveal a new breakthrough he calls the “AI Endgame.” In short, the final phase of the AI revolution is about to begin.

Tue, February 13 at 8:00PM ET

Days

Hours

Minutes

Seconds

Here’s how to prepare.

Biotech is defined as using technology to change, manipulate, and harness biological processes in order to fulfill a medical need. The applications of biotech are endless and range from genetically modifying foods to creating vaccines. During the height of the coronavirus pandemic, companies like Moderna and BioNTech utilized biotech to create life-saving vaccines that were distributed across the globe.

OLK Stock. Modern Medical Research Laboratory: Two Scientists Wearing Face Masks use Microscope, Analyse Sample in Petri Dish, Talk. Advanced Scientific Lab for Medicine, Biotechnology. Blue Color. KZR stock. RSLS stock

7 Biotech Stocks Fighting America’s Deadliest Diseases

Casava Sciences (NASDAQ:SAVA) stock jumped 9% Wednesday after the pharmaceutical company released promising data related to its clinical study of Simfilam, its proposed treatment for...

Biochemical/biotech research scientist team working with microscope

The 3 Most Undervalued Biotech Stocks to Buy in February 2024

With patience, some of the most undervalued biotech stocks can create massive wealth, such as these three to consider.

3 Biotech Stocks to Buy for the Next Bull Run: February 2024

These are the biotech stocks to buy that you must have on your watchlist for the coming bull run. It could get started as soon as this month.

Recent Biotech Stocks Articles

Cassava Sciences (SAVA) Stock Pops on Positive Results in Simufilam Trial

By Shrey Dua, InvestorPlace Assistant News Writer Feb 8, 2024

SAVA stock jumped 9% on Wednesday after Casava Sciences shared promising results of a clinical trial of its Alzheimer's treatment.

Why Is Tenax Therapeutics (TENX) Stock Down 64% Today?

By William White, InvestorPlace Writer Feb 8, 2024

Tenax Therapeutics stock is falling on Thursday after the company announced the pricing of a public offering for TENX shares.

7 Stocks to Sell as Fast as You Possibly Can

By Louis Navellier and the InvestorPlace Research Staff Feb 8, 2024

Don't be nostalgic about these. Dumping each of these stocks to sell now will go a long way toward saving your portfolio.

3 Sleeper Stocks Under $15 Ready to Explode by 2029

By Yiannis Zourmpanos, InvestorPlace Contributor Feb 7, 2024

These audacious innovators, all trading under $15, may erupt like financial volcanoes by 2029.

3 Biotech Stocks to Buy on the Dip: February 2024

By Chris Markoch, InvestorPlace Contributor Feb 7, 2024

Here are three biotech stocks to buy that are trading at prices that may not account for potential breakthrough opportunities

3 Stocks That AI Predicts Will Deliver Triple-Digit Returns This Year: February 2024

By Muslim Farooque, InvestorPlace Contributor Feb 7, 2024

Discover AI's top stock selections, meticulously analyzed for 2024, promising more than just returns but a revolution in your portfolio.

7 Tremendous Dividend Stocks With Double-Digit 5-Year Growth Rates

By Rich Duprey, InvestorPlace Contributor Feb 7, 2024

When it comes to buying dividend stocks, investors should seek out companies that consistently and reliably grow their payout over time.

The 7 Best Penny Stocks for 200% Returns

By Alex Sirois, InvestorPlace Contributor Feb 6, 2024

Penny stocks often possess significant upside and these are no different with 200% returns expected by analysts.

The New York Stock Exchange Will Start Delisting Invitae (NVTA) Stock

By Eddie Pan, InvestorPlace Financial News Writer Feb 6, 2024

The New York Stock Exchange has announced that it will begin the process of delisting NVTA stock based on its "abnormally low" price.

NVTA Stock: Invitae Plunges 78% on the Brink of Bankruptcy

By Larry Ramer, InvestorPlace Contributor Feb 6, 2024

NVTA stock tumbled yesterday amid a report that the firm could declare bankruptcy soon. The shares were halted for news pending.

Why Is InVivo Therapeutics (NVIV) Stock Up 61% Today?

By William White, InvestorPlace Writer Feb 6, 2024

InVivo Therapeutics stock is rising on Tuesday with heavy trading of NVIV shares as they remain volatile after a recent bankruptcy filing.

3 Fantastic Dow Stocks to Buy in February 2024

By Rich Duprey, InvestorPlace Contributor Feb 5, 2024

The venerable index is more representative of today's economy and these three Dow stocks to buy are brightly shining component stars.

3 Sleeper Stocks to Buy for the Next Bull Run: February 2024

By Muslim Farooque, InvestorPlace Contributor Feb 5, 2024

Embark on a savvy investing as we uncover three sleeper stocks and chart their stellar long-term potential to perform.

3 Magnificent Stocks to Buy on the Dip: February 2024

By Josh Enomoto, InvestorPlace Contributor Feb 5, 2024

While it’s a relative rarity because price generally discounts everything, that doesn’t mean you can’t find stocks to buy on dip. With thousands upon thousands...